Contact this trialFirst, we need to learn more about you.
Cholinergic Blocker for Cognitive Impairment
Recruiting0 awardsPhase < 1
Nashville, Tennessee
This trial will use a medicine that blocks a chemical called "acetylcholine" to study how it affects attention in people with Sickle Cell Disease. They think that people with SCD have to work harder to pay attention, and disrupting this process with the medicine will make it harder to pay attention.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service